In addition, the administrative claims databases used in this study do not contain information on clinical variables known to be prognostic for clinical worsening and death in PAH, such as functional class, 6MWD, right-sided heart catheterization findings, or levels of the biomarker N-terminal fragment of pro–brain natriuretic peptide.52 This evidence concerns the gene NPPB and pulmonary arterial hypertension.